SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Intarcia Therapeutics, Inc. and Quintiles, Inc. Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes